CHICAGO, April 15, 2026

AIRS Medical has announced that its SwiftMR® AI-powered MRI image enhancement solution has received FDA 510(k) clearance to operate in conjunction with original equipment manufacturer (OEM) deep learning reconstruction technologies, marking a significant advancement in AI-driven medical imaging and workflow optimization. The clearance enables healthcare providers to combine SwiftMR with existing OEM AI pipelines, delivering faster scan times, improved imaging efficiency, and enhanced patient throughput across clinical settings.

FDA Clearance Expands AI Integration in MRI Workflows

The newly granted FDA clearance allows SwiftMR® to seamlessly integrate with OEM deep learning reconstruction solutions, enabling imaging centers to enhance already accelerated MRI scans or extend AI capabilities to sequences not covered by OEM technologies. This dual functionality provides a flexible and scalable solution for healthcare providers seeking to maximize the performance of their existing MRI infrastructure.

In clinical practice, SwiftMR has demonstrated the ability to further reduce scan times even when OEM AI is already in use, with reported reductions from 15 minutes to approximately 9 minutes for routine brain MRI scans. Such improvements can significantly impact operational efficiency by enabling shorter appointment slots and increased patient capacity, addressing one of the major bottlenecks in radiology services.

AI-Powered Imaging Enhances Efficiency and Patient Experience

Advertisement

cGxPJobs Banner

SwiftMR® utilizes advanced deep learning algorithms to enhance MRI image quality while reducing acquisition time, offering a vendor-neutral solution compatible across different scanner types, field strengths, and imaging protocols. This broad compatibility ensures that healthcare providers can deploy the technology without requiring major hardware upgrades.

A key advantage of SwiftMR is its ability to provide full coverage across all pulse sequences and body parts, particularly in scenarios where OEM solutions may have limitations. This enables consistent application of AI-driven image enhancement and scan acceleration across diverse clinical use cases, including neurological, musculoskeletal, and abdominal imaging.

By reducing scan times by up to 50% in certain scenarios, SwiftMR contributes to improved patient comfort, reduced motion artifacts, and enhanced diagnostic workflow efficiency. Shorter scan durations also help minimize patient anxiety and increase accessibility for populations with difficulty remaining still during imaging procedures.

Strategic Impact on Imaging Centers and Healthcare Systems

The integration of SwiftMR with OEM AI solutions represents a major step toward fully AI-augmented radiology workflows, where multiple layers of intelligent processing work together to optimize imaging outcomes. For imaging centers and hospitals, this translates into greater operational flexibility, improved scheduling efficiency, and increased return on investment for existing MRI systems.

Healthcare providers can leverage the combined capabilities to transition from traditional 30-minute appointment slots to shorter 20-minute intervals, significantly increasing daily scan volumes without compromising image quality. This is particularly important in high-demand environments where MRI availability is limited and patient wait times are a critical concern.

Additionally, the FDA clearance reinforces confidence in the technology’s safety, performance, and regulatory compliance, supporting broader adoption across global healthcare markets. SwiftMR is already deployed in over 1,700 imaging centers across more than 40 countries, highlighting its growing role in modern radiology practices.

Advancing AI Innovation in Medical Imaging

The approval of SwiftMR for use alongside OEM deep learning solutions reflects a broader trend toward interoperable AI systems in healthcare, where multiple technologies collaborate to deliver superior outcomes. As AI continues to transform medical imaging, solutions that offer flexibility, scalability, and cross-platform compatibility will play a critical role in driving innovation.

From a regulatory perspective, this milestone underscores the importance of robust validation, quality assurance, and GxP-aligned development processes in bringing AI-based medical technologies to market. Ensuring that AI solutions meet stringent regulatory standards is essential for maintaining clinical trust, patient safety, and long-term adoption.

The FDA clearance of AIRS Medical’s SwiftMR® to operate alongside OEM deep learning solutions represents a significant advancement in AI-driven MRI technology, enabling faster scans, improved workflow efficiency, and enhanced patient experience. By combining vendor-neutral flexibility with advanced deep learning capabilities, SwiftMR is well-positioned to transform radiology workflows and support the future of intelligent medical imaging, reinforcing its role as a key innovation in the MedTech landscape.

Source: AIRS Medical press release